drugset / Trial / NCT01807702

13C-Pyruvate Breath Test

NCT01807702

Phase 1 Completed 5 enrolled University of Florida
NaSingle-groupOpen-labelHealth-services research

Summary

The purpose of the test is to measure an enzyme called pyruvate. Subjects will fast for 12 hours and then undergo a breath test, have blood drawn, and cells from the inside of the mouth collected over a 12 hour period. The tests will be repeated at least a week later and subjects receive a dose of dichloroacetate (DCA)

Timeline

Start
2013-03
Primary completion
2013-07
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dichloroacetate Small molecule 25 mg
Subject Hyperpolarized 13C-Pyruvate Diagnostic / imaging agent 25 mg
Background 13C-lactate Unknown

Indications

No indication recorded.